Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ANPCY NASDAQ:BIAFW OTCMKTS:EPGNY OTCMKTS:MBGNF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANPCYANGLEC$0.80+29.3%C$0.84C$0.61▼C$2.39N/AN/A1,291 shs856 shsBIAFWbioAffinity Technologies$0.10-1.2%$0.14$0.10▼$2.90N/AN/A10,990 shs1,200 shsEPGNYEpigenomics$2.39$2.39$2.01▼$2.39N/AN/A100 shsN/AMBGNFMany Bright Ideas Technologies$0.01$0.01$0.01▼$0.01N/AN/A600 shsN/AThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANPCYANGLE+29.31%+29.31%-8.84%-5.30%-53.24%BIAFWbioAffinity Technologies0.00%0.00%-37.50%-22.48%-93.75%EPGNYEpigenomics0.00%0.00%0.00%0.00%0.00%MBGNFMany Bright Ideas Technologies0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANPCYANGLEN/AN/AN/AN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AN/AN/AN/AMBGNFMany Bright Ideas TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANPCYANGLE 0.00N/AN/AN/ABIAFWbioAffinity Technologies 0.00N/AN/AN/AEPGNYEpigenomics 0.00N/AN/AN/AMBGNFMany Bright Ideas Technologies 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANPCYANGLEN/AN/AN/AN/AN/AN/ABIAFWbioAffinity Technologies$8.81MN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AN/AMBGNFMany Bright Ideas TechnologiesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANPCYANGLEN/A-C$0.48N/A∞N/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/AEPGNYEpigenomicsN/A-$3.05N/A∞N/AN/AN/AN/AN/AMBGNFMany Bright Ideas TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANPCYANGLEN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AMBGNFMany Bright Ideas TechnologiesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/AEPGNYEpigenomicsN/AMBGNFMany Bright Ideas TechnologiesN/AInsider OwnershipCompanyInsider OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/AEPGNYEpigenomicsN/AMBGNFMany Bright Ideas TechnologiesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANPCYANGLE173N/AN/ANot OptionableBIAFWbioAffinity Technologies10N/AN/ANot OptionableEPGNYEpigenomics32N/AN/ANot OptionableMBGNFMany Bright Ideas TechnologiesN/AN/AN/ANot OptionableMBGNF, ANPCY, BIAFW, and EPGNY HeadlinesRecent News About These CompaniesMBI.H:CA Many Bright Ideas Technologies Inc.February 20, 2025 | seekingalpha.comEstimating The Fair Value Of Many Bright Ideas Technologies Inc. (CVE:MBI.H)February 6, 2025 | finance.yahoo.comHow to build a multigenerational workforce to attract top talent and grow your businessNovember 5, 2024 | bizjournals.comFinding CuresOctober 30, 2024 | time.comTMicrosoft, Be My Eyes Announce New Joint Venture To ‘Drive AI Innovation’October 29, 2024 | forbes.comEngaging Fans: Four Content Ideas For MusiciansOctober 26, 2024 | forbes.comBright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial AnalysisOctober 22, 2024 | marketwatch.comLocal educators win Bright Ideas grantsOctober 19, 2024 | oxfordeagle.comOBright Minds Biosciences Shares Surge 70% on $35M Private PlacementOctober 18, 2024 | marketwatch.comBrightband sees a bright (and open source) future for AI-powered weather forecastingSeptember 20, 2024 | msn.comMusic Review: Bright Eyes’ 'Five Dice, All Threes' contemplates death, the Mets and much moreSeptember 18, 2024 | yahoo.comOne Way Technology Is Meeting Kids’ Mental Health ChallengesAugust 20, 2024 | forbes.comBright Eyes Announce Massive 2025 Tour, Reveal New Song “Rainbow Overpass”: StreamAugust 6, 2024 | yahoo.comCCEC's Bright Ideas Education Grant deadlines approachingAugust 4, 2024 | carolinacoastonline.comCTechnology, Talent and Transformation: Exploring NextGen IdeasJuly 23, 2024 | monitordaily.comM‘We’re so used to relying on technology.’ Hospitals, airlines, agency operations around New England hampered by software outage.July 20, 2024 | msn.comEfforts underway to create children’s book to mark Bright Nights 30th anniversaryMay 15, 2024 | msn.comMeet the fund manager: Finding the best ideas in the worldMay 13, 2024 | msn.comBright Ideas in Lighting for a More Productive WorkspaceMay 9, 2024 | startribune.comS3 Genius Ideas That Made Millions — Read This and Be Inspired!May 4, 2024 | yahoo.comMedia Sentiment Over TimeMBGNF, ANPCY, BIAFW, and EPGNY Company DescriptionsANGLE OTCMKTS:ANPCYC$0.80 +0.18 (+29.31%) As of 08/18/2025 02:21 PM EasternANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.bioAffinity Technologies NASDAQ:BIAFW$0.10 0.00 (-1.19%) As of 08/18/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.Epigenomics OTCMKTS:EPGNY$2.39 0.00 (0.00%) As of 04/6/2023Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.Many Bright Ideas Technologies OTCMKTS:MBGNF$0.01 0.00 (0.00%) As of 08/15/2025Many Bright Ideas Technologies Inc. does not have significant operations. It was previously engaged in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Medtronic: The Opportunity Gets Healthier for Income Investors Palo Alto Networks Uptrend Confirmed! New Highs Set by Year’s End Micron Stock Still Cheap Despite 25% Rally, Analysts Say Qualcomm Just Passed 1 Major Test, But Can It Pass the Next? Lyft's Billion-Dollar Signal: Why Wall Street Is Betting Big Joby Aviation: Why a Historic Flight Outweighs Analyst Downgrades Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks Grab Holdings: Get a Grip Now—Explosive Upside Brewing Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access